within Pharmacolibrary.Drugs.ATC.S;

model S01LA09
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.002033333333333333,
    adminDuration  = 600,
    adminMass      = 0.006,
    adminCount     = 1,
    Vd             = 0.00385,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Faricimab is a bispecific monoclonal antibody designed to bind and inhibit both angiopoietin-2 (Ang-2) and vascular endothelial growth factor A (VEGF-A). It is used for the treatment of neovascular (wet) age-related macular degeneration (nAMD) and diabetic macular edema (DME). Faricimab was approved by the US FDA in 2022 and is currently in clinical use.</p><h4>Pharmacokinetics</h4><p>PK parameters reported in patients with neovascular age-related macular degeneration (nAMD) receiving a 6 mg intravitreal dose.</p><h4>References</h4><ol><li>Cheikh Diack, Leonid Gibiansky, Felix Jaminion, Ekaterina Gibiansky, Jacques Gaudreault, Katrijn Bogman, Valerie Cosson,Ocular Pharmacokinetics of Faricimab Following Intravitreal Administration in Patients With Retinal Disease.,Translational vision science & technology,2024<a href='https://pubmed.ncbi.nlm.nih.gov/39535744/'>https://pubmed.ncbi.nlm.nih.gov/39535744/</a></li><li>Hansjürgen Agostini, Francis Abreu, Caroline R Baumal, Dolly S Chang, Karl G Csaky, Anna M Demetriades, Laurent Kodjikian, Jennifer I Lim, Philippe Margaron, Jordi M Monés, Tunde Peto, Federico Ricci, Matthias Rüth, Rishi P Singh, Ivaylo Stoilov, Balakumar Swaminathan, Jeffrey R Willis, Peter D Westenskow,Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes.,Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,2024<a href='https://pubmed.ncbi.nlm.nih.gov/38847896/'>https://pubmed.ncbi.nlm.nih.gov/38847896/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S01LA09;
